The DOI matches its Crossref record; the references it cites are not checked yet.
Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis
Open accessAbstract
In earlier works we have described that mice immunized with outer membrane protein OmpC survive the challenge with live Shigella flexnerii 3a. We have also identified conformational epitope of this protein, that was recognized by mice antibodies. The aim of current work was to investigate whether synthetic OmpC epitope homologs can elicit immunological response sufficient in protecting mice against shigellosis. Several linear peptides containing RYDERY motif were synthesized and conjugated to poly-lysine. These conjugates appeared to be poor immunogens and to boost the immunological response an addition of the adjuvant (MPL) was required. Unfortunately, the MPL alone caused a very high immunological reaction that was masking response to peptidic epitope. Under those circumstances we used tetanus toxoid (TT) as the carrier protein for the peptides and the agent stimulating immunological response. Series of cyclic peptides, homologs of the OmpC main epitope were synthesized and conjugated to TT. The loop size in cyclic peptides varied by number of glycine residues, i.e., 1-3 residues added to the GLNRYDERYIGK motif. The linear GLNRYDERYIGC-TT was also prepared as the control. The latter conjugate gave the highest immunological response, followed by the cyclic-GGLNRYDERYIGC-TT and cyclic-GLNRYDERYIGC-TT. The third peptide, cyclic-GGGLNRYDERYIGC-TT, gave a very low response, although it was the most resistant to proteolysis. However, antibodies obtained against cyclic-GGLNRYDERYIGC-TT were more potent to recognize both OmpC and Shigella flexnerii 3a cells than the antibodies against linear GLNRYDERYIGC-TT. Furthermore, the monoclonal antibodies raised against linear GLNRYDERYIGC-TT showed 20-fold lower dissociation constant (KD) than the naturally occurring polyclonal antibodies from umbilical cord sera. Monoclonal antibodies also gave a weaker signal in electron microscope than mice and human polyclonal antibodies. In overall, our results point to cyclic peptides as better candidates for a vaccine development, since they are eliciting production of the higher affinity antibodies against Shigella cells and OmpC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
References 18 · Cited by 15
Research works printed but not linked: 19
- Vinh, 2011, A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children, PLoS Negl Trop Dis, e1264, 10.1371/journal.pntd.0001264 · DOI
- Alajbegovic, 2012, Effectiveness of rifaximin and fluoroquinolones in preventing travelers’ diarrhea (TD): a systematic review and meta-analysis, Syst Rev, 1, 39, 10.1186/2046-4053-1-39 · DOI
- Nato, 2007, Dipstick for rapid diagnosis of Shigella flexneri 2a in stool, PLoS One, 2, e361, 10.1371/journal.pone.0000361 · DOI
- Kotloff, 2000, Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans, Infect Immun, 68, 1034, 10.1128/IAI.68.3.1034-1039.2000 · DOI
- Pore, 2011, Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model, PLoS One, 6, e22663, 10.1371/journal.pone.0022663 · DOI
- Witkowska, 2006, Enterobacterial 38-kDa outer membrane protein is an age-dependent molecular marker of innate immunity and immunoglobulin deficiency as results from its reactivity with IgG and IgA antibody, FEMS Immunol Med Microbiol, 48, 205, 10.1111/j.1574-695X.2006.00137.x · DOI
- Baslé, 2006, Crystal structure of osmoporin OmpC from E. coli at 2.0 A, J Mol Biol, 362, 933, 10.1016/j.jmb.2006.08.002 · DOI
- Jarząb, 2013, Shigella flexneri 3a outer membrane protein C epitope recognized by human umbilical cord sera and associated with protective activity, PLoS One, 8, e70539, 10.1371/journal.pone.0070539 · DOI
- Jarząb, 2011, Potential carrier for conjugate vaccines: OMP-38 protein from Shigella flexnerii 3a – isolation and purification strategies, Sepsis, 4, 39
- Arcidiacono, 2002, A rapid selective extraction procedure for the outer membrane protein (OmpF) from Escherichia coli, Protein Expr Purif, 25, 134, 10.1006/prep.2002.1619 · DOI
- Lowry, 1951, Protein measurement with the folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI
- Carter, 1994, Epitope mapping of a protein using the Geysen (PEPSCAN) procedure, Methods Mol Biol, 36, 207, 10.1385/0-89603-274-4:207 · DOI
- Habeeb, 1966, Determination of free amino groups in proteins by trinitrobenzenesulfonic acid, Anal Biochem, 14, 328, 10.1016/0003-2697(66)90275-2 · DOI
- Köhler, 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256, 495, 10.1038/256495a0 · DOI
- Rocque, 1987, Lipopolysaccharide tightly bound to porin monomers and trimers from Escherichia coli K-12, J Bacteriol, 169, 4003, 10.1128/jb.169.9.4003-4010.1987 · DOI
- Howell, 2014, Serum stable natural peptides designed by mRNA display, Sci Rep., 4, 6008, 10.1038/srep06008 · DOI
- Nguyen, 2010, Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs, PLoS One, 5, e12684, 10.1371/journal.pone.0012684 · DOI
- Pawlowski, 1999, A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines, Vaccine, 17, 1474, 10.1016/S0264-410X(98)00385-5 · DOI
- Gershoni, 2007, Epitope mapping: the first step in developing epitope-based vaccines, BioDrugs, 21, 145, 10.2165/00063030-200721030-00002 · DOI
Metadata
- Authors
- Jarząb, A., Witkowska, D., Ziomek, E., Setner, B., Czajkowska, A., Dorot, M., Szewczuk, Z., & Gamian, A.
- Affiliations
- Wroclaw Research Centre EIT+ (Poland) (PL)
- University of Wrocław (PL)
- Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL)
- Corresponding author
- Witkowska, Danuta
- Gamian, Andrzej
- ORCID
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 36
- Issue
- 31
- Pages
- 4641-4649
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2811229189
- Cited by
- 15
- References
- 18
- Citations by year
- 2025: 2 · 2024: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 7 · 2018: 1
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Vaccine (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Wroclaw Research Center EIT+ (01.01.02-02-003/08-00)
- European Regional Development Fund
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- shigellosis, cyclic peptides, tetanus toxoid conjugate, epitope-based vaccine, conformational epitopes, monoclonal antibodies, antibody affinity, protective immunity, adjuvants
- MeSH terms
- Adjuvants, Immunologic, Animals, Antibodies, Bacterial, Antibodies, Monoclonal, Epitopes, Antigens, Bacterial, Drug Carriers, Dysentery, Bacillary, Female, Mice, Inbred BALB C, Peptides, Cyclic, Tetanus Toxoid, Vaccines, Conjugate, Porins, Shigella Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis. https://app.cochat.ai/papers/10.1016/j.vaccine.2018.06.037
- The paper
- Jarząb, A., Witkowska, D., Ziomek, E., Setner, B., Czajkowska, A., Dorot, M., Szewczuk, Z., & Gamian, A. (2018). Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis. Vaccine. https://doi.org/10.1016/j.vaccine.2018.06.037
